ScholarGate
Asistente

Comparar métodos

Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.

Ensayo clínico de Fase II con emparejamiento×Estudio de cohortes emparejadas×
CampoEpidemiologíaEpidemiología
FamiliaProcess / pipelineProcess / pipeline
Año de origen1960s–1980s (formalized with Simon optimal designs, 1989)Mid-20th century; propensity-score variant 1983
Autor originalGehan (1961) for Phase II designs; matching frameworks adapted from case-control methodologyEstablished practice; propensity-score matching formalized by Rosenbaum & Rubin (1983)
TipoControlled clinical trial designObservational analytic study design
Fuente seminalGehan, E. A. (1961). The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. Journal of Chronic Diseases, 13(4), 346–353. DOI ↗Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641
Aliasmatched Phase II trial, historically matched Phase II study, propensity-matched Phase II trial, externally controlled Phase II trialmatched follow-up study, paired cohort study, propensity-matched cohort, matched prospective study
Relacionados55
ResumenA matched Phase II clinical trial is a single-arm or small-controlled early-efficacy study in which treated patients are paired with matched controls — drawn from historical databases, registries, or concurrent external cohorts — on key prognostic variables such as age, disease stage, and performance status. This design allows preliminary efficacy assessment without a concurrent randomized arm, trading randomization for feasibility while partially controlling for confounding through the matching process.A matched cohort study is an observational design in which each exposed participant is paired with one or more unexposed counterparts who share key characteristics — such as age, sex, or comorbidity status — before both groups are followed forward in time to compare incident outcomes. Matching controls for measured confounders at the design stage, reducing bias that would otherwise require statistical adjustment alone.
ScholarGateConjunto de datos
  1. v1
  2. 2 Fuentes
  3. PUBLISHED
  1. v1
  2. 2 Fuentes
  3. PUBLISHED

Ir a la búsqueda Descargar diapositivas

ScholarGateComparar métodos: Matched Phase II clinical trial · Matched Cohort Study. Recuperado el 2026-06-19 de https://scholargate.app/es/compare